SkinBioTherapeutics Plc
(LSE) SBTX
SkinBioTherapeutics Plc Financials at a Glance
Market Cap
$2.55B
Revenue (TTM)
$5.85M
Net Income (TTM)
$3.57M
EPS (TTM)
$-0.33
P/E Ratio
-29.85
Dividend
$0.00
Beta (Volatility)
0.02 (Low)
Dividend
$0.00
Beta (Volatility)
0.02 (Low)
Price
$9.85
Volume
2,054,113
Open
$10.00
Price
$9.85
Volume
2,054,113
Open
$10.00
Previous Close
$9.85
Daily Range
$9.50 - $11.00
52-Week Range
$5.00 - $27.50
Dividend
$0.00
Beta (Volatility)
0.02 (Low)
Price
$9.85
Volume
2,054,113
Open
$10.00
Previous Close
$9.85
Daily Range
$9.50 - $11.00
52-Week Range
$5.00 - $27.50
SBTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout SkinBioTherapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
41
CEO
Stuart John Ashman
Website
www.skinbiotherapeutics.comHeadquarters
Newcastle upon Tyne, NE4 5TF, GB
SBTX Financials
Key Financial Metrics (TTM)
Gross Margin
58%
Operating Margin
-24%
Net Income Margin
-15%
Return on Equity
-11%
Return on Capital
-11%
Return on Assets
-6%
Earnings Yield
-3.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.55B
Shares Outstanding
259.17M
Volume
2.05M
Short Interest
0.00%
Avg. Volume
4.50M
Financials (TTM)
Gross Profit
$2.71M
Operating Income
$826.79K
EBITDA
$196.54K
Operating Cash Flow
$1.30M
Capital Expenditure
$6.30K
Free Cash Flow
$1.30M
Cash & ST Invst.
$4.78M
Total Debt
$993.47K
SkinBioTherapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.06M
+5459.3%
Gross Profit
$1.83M
+32490.0%
Gross Margin
59.71%
N/A
Market Cap
$2.55B
N/A
Market Cap/Employee
$170.19M
N/A
Employees
15
N/A
Net Income
$337.85K
+121.8%
EBITDA
$657.80K
+140.6%
Quarterly Fundamentals
Net Cash
$3.79M
+212.6%
Accounts Receivable
$1.41M
+10346.8%
Inventory
$800.15K
+2288.7%
Long Term Debt
$881.35K
+1166.3%
Short Term Debt
$224.22K
+622.3%
Return on Assets
-5.74%
N/A
Return on Invested Capital
-10.54%
N/A
Free Cash Flow
$498.50K
+72.1%
Operating Cash Flow
$494.84K
+70.0%